Inventor
IWAMI MORITA
JP24 patents
⚠️ This page may combine multiple inventors who share the name “IWAMI MORITA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
15 patentsUS5192678AMar 9, 1993
Cephalosporin c acylase
FUJISAWA PHARMACEUTICAL CO24 citations91
US5320948AJun 14, 1994
Cephalosporin C acylase
FUJISAWA PHARMACEUTICAL CO16 citations80
US4863926ASep 5, 1989
Nitro aliphatic compounds, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations73
US4767768AAug 30, 1988
Nitro aliphatic compounds, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO10 citations73
US5677141AOct 14, 1997
Process for producing 7-aminocephem compound or salts thereof
FUJISAWA PHARMACEUTICAL CO12 citations72
US4782088ANov 1, 1988
Nitro aliphatic compounds and use thereof
FUJISAWA PHARMACEUTICAL CO1 citations62
US4778804AOct 18, 1988
Nitro aliphatic compounds, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO3 citations62
US4645765AFeb 24, 1987
Tetracyclo compounds and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO4 citations62
US4578271AMar 25, 1986
Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
FUJISAWA PHARMACEUTICAL CO7 citations60
US5310659AMay 10, 1994
GL-7ACA acylase
FUJISAWA PHARMACEUTICAL CO4 citations58
US4861774AAug 29, 1989
Method of treating tumors using tetracyclo compounds
FUJISAWA PHARMACEUTICAL CO0 citations51
US4743555AMay 10, 1988
Biologically pure culture of Streptomyces sandaensis No. 6897
FUJISAWA PHARMACEUTICAL CO1 citations51
US4950605AAug 21, 1990
FR-900493 substance, a process for its production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO1 citations50
US5312750AMay 17, 1994
GL-7ACA acylase
FUJISAWA PHARMACEUTICAL CO0 citations48
US4661352AApr 28, 1987
WS 7739 substances, their preparation and pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO0 citations39
OP BIO FACTORY CO LTD
7 patentsUS11066374B2Jul 20, 2021
Method for producing kakeromycin and derivatives thereof
OP BIO FACTORY CO LTD1 citations71
US10703732B2Jul 7, 2020
Method for producing kakeromycin and derivatives thereof
OP BIO FACTORY CO LTD1 citations71
US10618876B2Apr 14, 2020
Method for producing kakeromycin and derivatives thereof
OP BIO FACTORY CO LTD1 citations71
US10106509B2Oct 23, 2018
Method for producing kakeromycin and derivatives thereof
OP BIO FACTORY CO LTD2 citations71
US9896457B2Feb 20, 2018
Microbial product having antifungal activity
OP BIO FACTORY CO LTD3 citations64
US11753385B2Sep 12, 2023
Method for producing kakeromycin and derivatives thereof
OP BIO FACTORY CO LTD0 citations60
US11155526B2Oct 26, 2021
Method for producing kakeromycin and derivatives thereof
OP BIO FACTORY CO LTD0 citations60